Related Experiment Video
Updated: Jul 19, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Multiple sclerosis therapy monitoring based on gene expression
Robert Goertsches1, Pablo Serrano-Fernández, Steffen Möller
1Department of Immunology, University of Rostock, Schillingallee 70, D-18055 Rostock, Germany. robert.goertsches@med.uni-rostock.de
Current Pharmaceutical Design
|November 1, 2006
Summary
Multiple sclerosis (MS) research is advancing with transcriptome-level analysis. Understanding gene expression profiles offers new insights into disease mechanisms and personalized treatment strategies for this neurodegenerative disorder.
Area of Science:
- Neuroimmunology
- Genomics
- Translational Medicine
Background:
- Multiple sclerosis (MS) is a leading chronic autoimmune neurodegenerative disease of the central nervous system (CNS).
- Current treatments for MS and other autoimmune diseases show moderate effectiveness, necessitating novel therapeutic approaches.
- Future treatments may involve combination therapies, including immunomodulation, pathogen elimination, and tissue repair.
Purpose of the Study:
- To review the current state of multiple sclerosis research at the transcriptome level using genome-wide screening methods.
- To explore the implications of transcriptome analysis for understanding MS pathogenicity and identifying diagnostic markers.
- To discuss the potential for transcriptome data in discovering new therapeutic targets and enabling tailored patient therapies.
Main Methods:
- Review of existing literature on genome-wide screening methods in multiple sclerosis research.
- Analysis of transcriptome data to identify gene expression patterns relevant to MS.
- Discussion of the translation of genomic findings into clinical applications.
Main Results:
- Genome-wide RNA profiling serves as a powerful approach to understanding MS biology.
- Gene expression profiles can correlate with drug therapy outcomes and side effects.
- Transcriptome analysis aids in identifying potential diagnostic markers and therapeutic targets.
Conclusions:
- Transcriptome-level research is crucial for advancing our understanding of multiple sclerosis.
- Identifying gene expression signatures can lead to improved diagnostic tools and personalized treatment strategies.
- This approach supports the development of tailored therapies for MS patients.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...